Technology-Enhanced Quitline Services to Prevent Smoking Relapse

技术增强的戒烟热线服务可防止复吸

基本信息

项目摘要

DESCRIPTION (provided by applicant): Each year, over 19 million Americans smokers stop smoking for more than one day in an attempt to quit smoking, yet as few as 5% will maintain abstinence for one year, with most returning to smoking within one month of quitting. Relapse after smoking cessation is an important health concern and is the most significant problem faced by individuals who are attempting to maintain abstinence from smoking. The purpose of this study is to test the efficacy of IVR technology for enhancing a widely used tobacco treatment service delivery model (Free & Clear's Quit for Life(R) program) to prevent smoking relapse and achieve abstinence. Our technology will enhance quitline services through (1) screening individuals during the post quit date period for increased risk of relapse and (2) providing evidence-based telephone counseling at the point of need tailored to the individual's extant risk factors. Using IVR monitoring, individuals will be screened for specific indicators of increased risk for relapse including smoking lapse, physical withdrawal symptoms, depressive symptoms, perceived stress, decreased self-efficacy for quitting, and decreased motivation to quit. In addition to these well-established predictors of relapse, there is compelling evidence to suggest that the risk of relapse is most intense during the first two weeks post-quit. Thus we propose to compare two models for timing and frequency of IVR screening. In the Technology Enhanced Quitline (TEQ) arm, 10 proactive IVR calls will be placed at decreasing frequency for 8 weeks post-quit (twice a week for the first two weeks, then weekly). In the High Intensity Technology-Enhanced Quitline (HI-TEQ) arm, 20 proactive IVR calls will be placed over the 8 weeks post-quit (daily for the first 2 weeks, then weekly). The proposed study is a randomized controlled trial to compare smoking abstinence and cost-effectiveness at 6 and 12 months among participants in the Quit for Life quitline program. Three treatment groups will be compared, namely (1) standard Quit for Life care, (2) IVR monitoring of risk for smoking relapse in combination with telephone-based tobacco cessation treatment service (TEQ), and (3) high frequency monitoring of risk for smoking relapse in combination with telephone- based tobacco cessation treatment service (HI-TEQ). Subjects will be recruited from three large clients (two employers and one health plan client) of the Free & Clear Quit for Life telephone-based tobacco cessation treatment program. If successful, this intervention could be incorporated into existing quitline protocols and delivered to millions of individuals who are trying to quit smoking, meeting a significant public health need for the dissemination of effective smoking cessation interventions.
描述(由申请人提供):每年有超过1900万美国人吸烟者停止吸烟超过一天,以试图戒烟,但是只有5%的人将在戒烟的一个月内恢复戒烟,而大多数人会戒烟一年。戒烟后复发是一个重要的健康问题,是试图维持戒烟的人所面临的最重大问题。这项研究的目的是测试IVR技术的功效,以增强广泛使用的烟草治疗服务传递模型(Free&Clear for Life(R)计划),以防止吸烟复发并实现禁欲。我们的技术将通过(1)在退出日期期间筛选个人来增强戒烟服务,以增加复发风险,以及(2)在针对个人现存的风险因素量身定制的需求点上提供基于证据的电话咨询。使用IVR监测,将筛选个体,以了解复发风险增加的特定指标,包括吸烟,身体戒断症状,​​抑郁症状,感知的压力,戒烟的自我效能减弱以及戒烟动机的降低。除了这些良好的复发预测指标外,还有令人信服的证据表明,在Quit后的头两周,复发的风险最为强烈。因此,我们建议比较两个模型的时间和IVR筛选频率。在技​​术增强的Quitline(TEQ)组中,将在Quitt后8周以降低的频率下降10个主动的IVR呼叫(每周两周两次,然后每周一次)。在高强度技术增强的Quitline(HI-TEQ)组中,将在Quit后8周内进行20个主动的IVR呼叫(每天在头2周,然后每周一次)。拟议的研究是一项随机对照试验,以比较戒烟戒烟计划的参与者中6和12个月的戒烟和成本效益。将比较三个治疗组(即(1)终身护理的标准戒烟,(2)IVR监测吸烟风险与基于电话的戒烟戒烟治疗服务(TEQ)以及(3)高频监测与电话基于电话基于电话的托巴科污型治疗服务(HI-TEQ)相结合的风险的风险。受试者将从三个大型客户(两个雇主和一个健康计划客户)中招募,以终身为基于电话的烟草戒烟治疗计划。如果成功,则可以将这种干预措施纳入现有的戒烟方案中,并交付给数百万试图戒烟的人,满足公共卫生的巨大健康需求,以传播有效的戒烟干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Victoria Lee Champion其他文献

Variables Related to Breast Self-Examination: Model Generation
与乳房自检相关的变量:模型生成
  • DOI:
    10.1111/j.1471-6402.1992.tb00241.x
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Victoria Lee Champion;T. K. Miller
  • 通讯作者:
    T. K. Miller

Victoria Lee Champion的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Victoria Lee Champion', 18)}}的其他基金

Implementing evidence based colorectal cancer screening in rural clinics
在农村诊所实施循证结直肠癌筛查
  • 批准号:
    10567653
  • 财政年份:
    2023
  • 资助金额:
    $ 39.85万
  • 项目类别:
Comparative Effectiveness of Interventions to Improve Screening Among Rural Women
改善农村妇女筛查干预措施的比较有效性
  • 批准号:
    9310329
  • 财政年份:
    2015
  • 资助金额:
    $ 39.85万
  • 项目类别:
Comparative Effectiveness of Interventions to Improve Screening Among Rural Women
改善农村妇女筛查干预措施的比较有效性
  • 批准号:
    8987262
  • 财政年份:
    2015
  • 资助金额:
    $ 39.85万
  • 项目类别:
Research and Training for Behavioral Oncology Interventions
行为肿瘤学干预研究和培训
  • 批准号:
    9067236
  • 财政年份:
    2014
  • 资助金额:
    $ 39.85万
  • 项目类别:
Research and Training for Behavioral Oncology Interventions
行为肿瘤学干预研究和培训
  • 批准号:
    8700057
  • 财政年份:
    2014
  • 资助金额:
    $ 39.85万
  • 项目类别:
Research and Training for Behavioral Oncology Interventions
行为肿瘤学干预研究和培训
  • 批准号:
    8841693
  • 财政年份:
    2014
  • 资助金额:
    $ 39.85万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    8115781
  • 财政年份:
    2010
  • 资助金额:
    $ 39.85万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    7890201
  • 财政年份:
    2010
  • 资助金额:
    $ 39.85万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    8470132
  • 财政年份:
    2010
  • 资助金额:
    $ 39.85万
  • 项目类别:
Increasing Colorectal and Breast Cancer Screnning in Women
增加女性结直肠癌和乳腺癌筛查
  • 批准号:
    8270610
  • 财政年份:
    2010
  • 资助金额:
    $ 39.85万
  • 项目类别:

相似国自然基金

精神分裂症谱系的快感缺失:基于情感神经科学的脑成像研究
  • 批准号:
    81571317
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Orexin modulation of brain reward-brain stress system interactions in alcohol withdrawal anxiety
食欲素调节酒精戒断焦虑中大脑奖赏-大脑应激系统相互作用
  • 批准号:
    10302090
  • 财政年份:
    2022
  • 资助金额:
    $ 39.85万
  • 项目类别:
A Biopsychobehavioral Investigation of Withdrawal from Ultra-Processed Food in Humans
人类超加工食品戒断的生物心理行为研究
  • 批准号:
    10704765
  • 财政年份:
    2022
  • 资助金额:
    $ 39.85万
  • 项目类别:
A Biopsychobehavioral Investigation of Withdrawal from Ultra-Processed Food in Humans
人类超加工食品戒断的生物心理行为研究
  • 批准号:
    10518910
  • 财政年份:
    2022
  • 资助金额:
    $ 39.85万
  • 项目类别:
Clinical Course of Alcohol Use Disorder Recovery
酒精使用障碍康复的临床过程
  • 批准号:
    10585118
  • 财政年份:
    2022
  • 资助金额:
    $ 39.85万
  • 项目类别:
Dissecting the contribution of glutamatergic ventral pallidal neurons to the aversive state of opioid withdrawal
剖析谷氨酸能腹侧苍白球神经元对阿片类药物戒断厌恶状态的贡献
  • 批准号:
    10464731
  • 财政年份:
    2022
  • 资助金额:
    $ 39.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了